文献速递产科母胎医学

妊娠期孕激素试验与系统评价中是否存在无意的P-hacking?一项系统评价与Meta分析

Inadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis.
PubMed 文献 · BJOG · 2017-03-20

该研究通过检索PubMed、Cochrane图书馆和试验注册库,比较所有孕激素试验与系统评价同预先注册主要结局试验的发现。29项Meta分析中19项结论为孕激素有效;22项报告预先注册主要结局的试验中,孕酮对注册的二分类主要结局无效应,RR 1.00(95%CI 0.94-1.07),仅1项显示名义统计学显著获益。作者结论:在注册的双盲试验中分析限定于预设主要结局时,妊娠期孕激素制剂无效。

要点

  • 29项Meta分析中19项结论为孕激素有效,但22项预先注册主要结局的试验汇总显示孕酮对注册二分类结局无效应。
  • 孕酮对预先注册二分类主要结局的RR为1.00(95%CI 0.94-1.07)。
  • 22项报告预先注册主要结局的试验中仅1项显示名义统计学显著获益。

核心结论

  • 在注册的双盲试验中分析限定于预设主要结局时,妊娠期孕激素制剂无效。
  • 作者认为早期研究和系统评价可能因选择性发表或选择性选择结局(即P-hacking)而产生偏倚。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Cochrane图书馆和试验注册库,注册号PROSPERO CRD42016035303。
  • 纳入妊娠期比较孕激素与安慰剂的随机试验的系统评价及这些评价中纳入的单个试验。
  • 将报告预先注册主要结局的试验子集与全部试验和系统评价进行比较。
  • 系统评价纳入所有结局;单个试验纳入系统评价中报告的所有结局;比较组记录在试验开始前注册、或在招募阶段注册且为双盲的试验的注册主要结局。

主要发现

  • 29项Meta分析中19项结论为孕激素有效。
  • 22项试验报告了预先注册的主要结局。
  • 孕酮对注册的二分类主要结局无效应,RR 1.00(95%CI 0.94-1.07)。
  • 22项报告预先注册主要结局的试验中仅1项显示名义统计学显著获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Progestogens have been evaluated in numerous trials and meta-analyses, many of which concluded they were effective. However, two large trials PROMISE and OPPTIMUM have recently concluded that progesterone was ineffective. This raises the possibility that earlier studies and reviews had been biased by either selective publication or selective choice of outcomes, so called "P-hacking". OBJECTIVES: To compare the findings all progestogen trials and systematic reviews with those of trials with pre-registered primary outcomes which avoided selective outcome reporting. SEARCH STRATEGY: Search of PubMed, the Cochrane Library and trial registries. Registration PROSPERO CRD42016035303. SELECTION CRITERIA: Systematic reviews of randomised trials comparing progestogen with placebo in pregnancy and the individual trials included in those reviews. The subset of trials reporting a pre-registered primary outcome were compared with the totality of trials and reviews. DATA COLLECTION AND ANALYSIS: For reviews all outcomes were included. For individual trials all outcomes reported in the systematic reviews were included. For the comparison group we recorded the registered primary outcome from trials that were either registered before they started, or registered during the recruitment phase and also double blind. MAIN RESULTS: Nineteen of twenty-nine meta-analyses concluded that progestogens were effective. Twenty-two trials reported their pre-registered primary outcomes. There was no effect of progesterone on primary registered dichotomous outcome RR 1.00 (95% CI 0.94-1.07). Only one of the 22 showed a nominally statistically significant benefit. AUTHOR'S CONCLUSIONS: When evaluated in registered double-blind trials with analysis restricted to predefined primary outcomes, progestational agents in pregnancy are ineffective. TWEETABLE ABSTRACT: Progestogens to prevent pregnancy loss, an example of P-hacking.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Prior M, Hibberd R, Asemota N, et al. Inadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis. BJOG. 2017. PMID: 28318099. doi:10.1111/1471-0528.14506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。